total
clinic
specimen
nasal
swab
nasopharyng
aspir
test
flursv
xc
result
compar
obtain
realtim
retro
transcriptasepolymeras
chain
reaction
assay
routin
use
laboratori
flursv
xc
show
sensitivityspecif
flu
respiratori
syncyti
viru
respect
rapid
identif
respiratori
pathogen
help
improv
manag
patient
term
prevent
cur
measur
salez
et
al
today
realtim
retro
transcriptasepolymeras
chain
reaction
rtrtpcr
refer
test
detect
respiratori
virus
clinic
microbiolog
laboratori
howev
test
still
requir
extens
handson
time
averag
analyt
turnaround
time
hour
rapid
immunochromatograph
test
detect
viral
antigen
averag
turnaround
time
min
excel
specif
sp
still
hamper
limit
sensit
se
necessit
confirm
neg
result
use
techniqu
present
optim
se
aslanzadeh
et
al
falsey
et
al
paulson
zazuetagarcia
et
al
genexpert
system
cepheid
franc
design
nucleic
acid
extract
rtpcr
amplif
realtim
detect
use
singleus
dispos
cartridg
autom
platform
cepheid
flursv
xc
assay
allow
determin
infect
caus
influenza
virus
flu
inclus
human
avian
strain
influenza
b
virus
flu
b
respiratori
syncyti
virus
rsv
within
min
determin
se
sp
posit
predict
valu
neg
predict
valu
result
obtain
flursv
xc
compar
observ
singleplex
rtrtpcr
test
routin
use
virolog
laboratori
diagnost
purpos
duchamp
et
al
kim
et
al
van
elden
et
al
van
elden
et
al
total
nasal
swab
n
nasopharyng
aspir
n
sampl
select
sampl
posit
flu
rsv
virus
randomli
sort
larg
number
posit
specimen
receiv
year
diagnost
purpos
virolog
laboratori
public
hospit
system
marseil
flu
b
due
small
number
case
observ
year
frozen
sampl
preced
year
sort
use
approach
dualposit
sampl
test
flu
flu
b
rsv
human
metapneumoviru
hmpv
rhinoviru
identifi
select
stage
exclud
panel
age
class
year
year
year
year
year
year
number
patient
sex
ratio
respect
sampl
test
flu
duchamp
et
al
kim
et
al
flu
b
van
elden
et
al
rsv
van
elden
et
al
hmpv
maertzdorf
et
al
human
rhinoviru
hrv
lu
et
al
use
routin
rtrtpcr
assay
human
parainfluenzavirus
coronavirus
hcov
test
rtrtpcr
hcovhpiv
kit
marci
letoil
franc
use
synthet
rna
control
sensit
refer
test
flu
flu
b
rsv
determin
ninov
et
al
respect
genomecopiesreact
laboratori
particip
qcmd
extern
qualiti
assur
flu
rsv
test
perform
use
refer
assay
describ
studi
duchamp
et
al
kim
et
al
van
elden
et
al
van
elden
et
al
provid
perform
equal
better
xpert
flursv
result
observ
frozen
sampl
discrep
compar
previous
obtain
use
refer
method
rtrtpcr
fresh
sampl
refer
method
perform
frozen
sampl
whether
frozen
sampl
test
use
refer
assay
neg
therefor
discrep
compar
initi
result
consid
freez
step
degrad
sampl
consid
neg
assay
thu
concordantli
neg
ii
whether
frozen
sampl
still
posit
refer
assay
consid
discrep
eightynin
sampl
posit
flu
virus
b
rsv
rsva
rsvb
neg
virus
sampl
either
posit
hmpv
n
hcov
n
hrv
n
neg
n
test
virus
tabl
sampl
test
flursv
xc
accord
manufactur
recommend
test
retrospect
storag
ii
test
prospect
parallel
refer
assay
fresh
sampl
frozen
tabl
detail
result
compar
studi
present
tabl
briefli
import
underlin
indetermin
result
observ
flursv
xc
assay
ii
none
sampl
neg
flu
rsv
refer
test
found
posit
use
flursv
xc
assay
thu
yield
sp
target
virus
iii
sampl
posit
flu
virus
use
rtrtpcr
posit
flu
rsv
xc
assay
se
flu
flu
b
flu
flu
b
sampl
posit
rsv
use
rtrtpcr
posit
flursv
xc
assay
se
rsva
rsvb
rsva
rsvb
interestingli
mean
cycl
treshold
ct
sd
sampl
flu
virus
detect
test
contrast
sampl
test
discrepantli
neg
use
flursv
xc
present
ct
valu
man
woman
suggest
low
viral
load
might
reason
discrep
situat
appli
rsv
detect
mean
ct
sd
sampl
found
contain
rsv
rna
method
aforement
sampl
discrepantli
neg
use
flursv
xc
ct
valu
boy
woman
although
limit
number
sampl
show
discrep
result
techniqu
preclud
statist
analysi
notic
similar
find
previous
report
salez
et
al
studi
panel
select
inform
sensit
assay
hous
assay
show
good
perform
sensit
allow
comparison
realist
evalu
cost
done
base
consolid
budget
calcul
includ
reagent
personnel
time
equip
amort
depreci
also
take
account
time
spent
patient
emerg
room
delay
discharg
econom
calcul
difficult
usual
believ
done
specif
situat
specif
hospit
transfer
appli
due
mani
differ
paramet
may
flaw
model
best
knowledg
flursv
xc
commerci
avail
test
suitabl
point
care
set
ii
demonstr
se
sp
compat
definit
biolog
valid
without
need
confirmatori
test
salez
et
al
therefor
xpert
flursv
xc
assay
detect
import
viral
pathogen
simultan
fulfil
prerequisit
paramet
practic
use
clinic
set
conclus
recent
introduc
flursv
xc
assay
show
perform
fulli
compat
use
routin
test
pointofcar
test
without
need
confirmatori
test
